Skip to main content
Clinical Trials/NL-OMON37018
NL-OMON37018
Completed
Phase 3

Paracetamol intravenously in neonates with a gestational age of less than 32 weeks - PIN32

Maxima Medisch Centrum0 sites15 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
nociceptie
Sponsor
Maxima Medisch Centrum
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • Gestational age less than 32 weeks
  • Analgesia indicated as per pain protocol
  • Indwelling arterial catheter available
  • Informed consent

Exclusion Criteria

  • Co\-medication: analgesia, sedatives, muscle relaxants, phenobarbital
  • Asphyxiated patients
  • Signs of liver failure prior to inclusion

Outcomes

Primary Outcomes

Not specified

Similar Trials